A cross-sectional study using the Childrens Dermatology Life Quality Index (CDLQI) in childhood psoriasis: Negative effect on quality of life and moderate correlation of CDLQI with severity scores

British Journal of Dermatology

Volumn 163, Issue 5, 2010, Pages 1099-1101

  De Jager, M E A ^a   Van De Kerkhof, P C M ^a   De Jong, E M G J ^a   Seyger, M M B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Children; Childrens Dermatology Life Quality Index; Juvenile psoriasis; Physician Global Assessment; Psoriasis Area and Severity Index; Quality of life

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL DECISION MAKING; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZED CHILD; HUMAN; MALE; OUTPATIENT; OUTPATIENT DEPARTMENT; PARAMETER; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL CHILD;

ADOLESCENT; CHILD; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 78249231742     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09993.x     Document Type: Article

References (15)

1. Augustin M, Glaeske G, Radtke MA, et al. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2010; 162: 633 -6.
2. Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537 -41.
3. De Jager ME, Van De Kerkhof PC, De Jong EM, et al. Epidemiology and prescribed treatments in childhood psoriasis: a survey among medical professionals. J Dermatolog Treat 2009; 20: 254 -8.
4. Long CC, Funnell CM, Collard R, et al. What do members of the National Eczema Society really want? Clin Exp Dermatol 1993; 18: 516 -22.
5. Beattie PE, Lewis-Jones MS,. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006; 155: 145 -51.
6. Lewis-Jones MS, Finlay AY,. The Childrens Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132: 942 -9.
7. Fredriksson T, Pettersson U,. Severe psoriasis -oral therapy with a new retinoid. Dermatologica 1978; 157: 238 -44.
8. Holme SA, Man I, Sharpe JL, et al. The Childrens Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003; 148: 285 -90.
9. Steiger JH,. Tests for comparing elements of a correlation matrix. Psychol Bull 1980; 87: 245 -51.
10. Sampogna F, Sera F, Abeni D,. Measures of clinical severity, quality of life, and psychological distress in patients with psoriasis: a cluster analysis. J Invest Dermatol 2004; 122: 602 -7.
11. Fortune DG, Main CJ, OSullivan TM, et al. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755 -60.
12. Touw CR, Hakkaart-van Roijen L, Verboom P, et al. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001; 144: 967 -72.
13. Schäfer I, Hacker J, Rustenbach SJ, et al. Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. Eur J Dermatol 2010; 20: 62 -7.
14. Annett RD, Bender BG, Lapidus J, et al. Predicting childrens quality of life in an asthma clinical trial: what do childrens reports tell us? J Pediatr 2001; 139: 854 -61.
15. Reich K, Griffiths CE,. The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab. Arch Dermatol Res 2008; 300: 537 -44.